New shoulder implant tested for arthritis and rotator cuff tears
NCT ID NCT04431973
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a shoulder replacement device called the Medacta Shoulder System in 100 people with shoulder arthritis or rotator cuff tears. The goal is to see how well the implant works after 2 years, focusing on shoulder function, safety, and patient satisfaction. Participants receive the implant during surgery and are followed for up to 2 years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Medacta Shoulder System (reverse shoulder prosthesis)
- What this could lead to
- If successful, this could confirm that the Medacta Shoulder System provides reliable pain relief and improved shoulder function for people with severe shoulder conditions.
- What could go wrong
- This is a post-market study with no control group, so results may not prove superiority over other prostheses. Complications like infection or implant loosening are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MASSIVE CUFF TEAR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chu Angers
Angers, France
-
Chu Rennes
Rennes, France
-
Chu Tours
Tours, France
-
Clinique Mutualiste la Sagesse
Rennes, France
-
Polyclinique santé atlantique
Saint-Herblain, France